Page 21 - Trinity Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global infectious disease diagnostics market is growing at a CAGR of 6.8% from 2021 to 2028.Pune, India., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Tuberculosis (TB) is the 13th most significant cause of mortality globally and the second leading infectious disease after COVID-19, according to the World Health Organization (WHO). According to the WHO, there were 1.5 million deaths due to TB in 2020 (including 214,000 HIV patients). WHO estimated that TB would affect 10 million individuals worldwide in 2

Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The

Global Market for D-dimer Testing Global Market for D-dimer Testing Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "D-dimer Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global D-dimer Testing market, valued at approximately $1.3 billion in 2022, is anticipated to expand to over $1.8 billion by the year 2030. This growth is expected to occur at a steady Compound Annual Growth Rate (CAGR) of 4% during the analysis period spanning from 2

The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033.The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, an...

Analysts’ new coverage for Wednesday, September 13th: StockNews.com assumed coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Wells Fargo & Company began coverage on shares of Ares Commercial Real […]